KLA Corporation (KLAC) Q1 2025 10-Q Quarterly Report

Filed: May 1, 2025Period ending Mar 31, 2025
Health Care
Optical Instruments & LensesSEC EDGAR

KLA Corporation (KLAC) 10-Q quarterly report for Q1 2025, filed with SEC EDGAR on May 1, 2025 for the fiscal period ending Mar 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

KLA Corporation Q1 2025 10-Q Analysis

Management Discussion & Analysis

  • Working capital $6.04B as of Mar 31, 2025, up $664.7M from $5.37B on June 30, 2024
  • Cash, cash equivalents, and marketable securities $4.03B plus $1.50B available under Revolving Credit Facility
+3 more insights

Risk Factors

  • New risk: potential repurchase obligation under Senior Notes triggered by downgrade by 2+ rating agencies, requiring 101% principal repayment plus interest
  • Material update: Revolving Credit Facility interest rate now linked to sustainability KPIs on GHG emissions and renewable electricity usage
+3 more insights

KLA Corporation Q1 2025 Quarterly Financials
XBRL

Revenue

$3.1B

+29.8% YoY -0.4% QoQ

Net Income

$1.1B

+80.9% YoY +32.0% QoQ

Net Margin

35.5%

+1004bp YoY +874bp QoQ

EPS (Diluted)

$8.15

+84.4% YoY +32.3% QoQ

Operating Cash Flow

$1.1B

+17.8% YoY +26.2% QoQ

Source: XBRL data from KLA Corporation Q1 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other KLA Corporation Quarterly Reports

Get deeper insights on KLA Corporation

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.